Skip to main content
. Author manuscript; available in PMC: 2025 Sep 1.
Published in final edited form as: Gynecol Oncol. 2024 Jun 27;188:52–57. doi: 10.1016/j.ygyno.2024.06.008

Figure 1: Folate receptor alpha (FRα) immunohistochemistry in low-grade serous carcinoma.

Figure 1:

Representative examples of FRα-negative tumors: samples from different patients taken from ovary (left) and colon metastasis (right), and FRα-high tumors: samples from different patients taken from ovary (left) and peritoneal metastasis (right). The percentage of FRα-positive tumor cells (2+/3+ intensity) is indicated for each sample.